Abrogation of MRL/lpr Lupus Nephritis by Dietary Flaxseed

Brenner, 1982, Dietary protein intake and the progressive nature of kidney disease: The related hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease, N Engl J Med, 307, 652, 10.1056/NEJM198209093071104

Klahr, 1983, Role of dietary factors in the progression of chronic renal disease, Kidney Int, 24, 579, 10.1038/ki.1983.197

Nath, 1986, Dietary protein restriction in established renal injury in the rat, J Clin Invest, 78, 1199, 10.1172/JCI112703

Clark, 1989, Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus, Kidney Int, 36, 653, 10.1038/ki.1989.242

Clark, 1989, Fish oil therapy in kidney disease, 303

Clark, 1990, Comparative efficacy of dietary treatments on renal function in rats with sub-total nephrectomy: Renal polyunsaturated fatty acid incorporation and prostaglandin excretion, Clin Nephrol, 33, 25

Clark, 1991, Chronic effects of ω-3 fatty acids (fish oil) in a rat 5/6 renal ablation model, J Am Soc Nephrol, 1, 1343, 10.1681/ASN.V1121343

Hall, 1992, Omega-3 fatty acid supplementation in primary nephrotic syndrome: Effects on plasma lipids and coagulopathy, J Am Soc Nephrol, 3, 1321, 10.1681/ASN.V361321

Theofilopoulous, 1985, Murine models of lupus erythematosus, Adv Immunol, 37, 269, 10.1016/S0065-2776(08)60342-9

Urowitz, 1976, The bimodal mortality of systemic lupus erythematosus, Am J Med, 60, 221, 10.1016/0002-9343(76)90431-9

Karsh, 1979, Mortality in lupus nephritis, Arthritis Rheum, 22, 764, 10.1002/art.1780220712

Correia, 1985, Why do patients with lupus nephritis die?, Br Med J, 290, 126, 10.1136/bmj.290.6462.126

Kelley, 1991, Dietary α-linolenic acid and immunocompetence in humans, Am J Clin Nutr, 53, 40, 10.1093/ajcn/53.1.40

Thompson, 1991, Mammalian lignan production for various foods, Nutr Cancer, 16, 43, 10.1080/01635589109514139

Shen, 1990, Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor, Methods Enzymol, 187, 446, 10.1016/0076-6879(90)87051-4

Choi, 1988, Effects of dietary alpha- and gamma-linolenic acid on lipid metabolism in young and adult rats, Ann Nutr Metab, 32, 169, 10.1159/000177430

Singer, 1990, Effects of dietary oleic, linoleic and a-linolenic acids on blood pressure, serum lipids, lipoproteins and the formation of eicosanoid precursors in patients with mild essential hypertension, J Hum Hypertens, 4, 227

Macconi, 1991, Increased urinary excretion of platelet activating factor in mice with lupus nephritis, Life Sci, 48, 1429, 10.1016/0024-3205(91)90179-F

Morigi, 1991, Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice, J Pharmacol Exp Ther, 258, 601

Baldi, 1990, Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus, Kidney Int, 38, 1030, 10.1038/ki.1990.309

Tetta, 1990, Release of platelet-activating factor in systemic lupus erythematosus, Int Arch Allergy Appl Immunol, 91, 244, 10.1159/000235124

Myers, 1983, Glucocorticoid protection against PAF-acether toxicity in mice, Br J Pharmacol, 79, 595, 10.1111/j.1476-5381.1983.tb11034.x

Jobin, 1985, Measurement of glomerular filtration rates in conscious unrestrained rats with inulin infused by implanted osmotic pumps, Am J Physiol, 248, F734

Camussi, 1982, Platelet-activating factor (PAF) in experimentally induced rabbit acute serum sickness; role of basophilderived PAF in immune-complex deposition, J Immunol, 128, 86, 10.4049/jimmunol.128.1.86

Camussi, 1981, Release of platelet-activating factor in human pathology: Evidence for the occurence of basophil degranulation and release of plateletactivating factor in systemic lupus erythematosus, Lab Invest, 44, 241

Ito, 1984, Hyperacute renal allograft rejection in the rabbit: The role of platelet activating factor and of cationic proteins derived from polymorphonuclear leucocytes and from platelets, Lab Invest, 51, 148

Camussi, 1987, Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin, J Lab Clin Med, 110, 196

Perico, 1991, Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats, Am J Physiol, 261, F85

Cox, 1987, Selective antagonism of plateletactivating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam, Thromb Res, 47, 249, 10.1016/0049-3848(87)90138-1

Camussi, 1984, Platelet-activating factor-induced loss of glomerular anionic charges, Kidney Int, 25, 73, 10.1038/ki.1984.10

Altman, 1981, Analysis of T cell function in autoimmune murine strains, defects in production of, and responsiveness to, interleukin-2, J Exp Med, 154, 791, 10.1084/jem.154.3.791

Patrignani, 1987, Platelet activating factor (PAF) receptor antagonists inhibit mitogeninduced human blood T cell proliferation, Biochem Biophys Res Commun, 148, 802, 10.1016/0006-291X(87)90947-8